- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 12.06. | JPMorgan raises Santen Pharmaceutical price target on medium-term plan | 1 | Investing.com | ||
| 12.06. | JPMorgan erhöht Kursziel für Santen Pharmaceutical aufgrund mittelfristigen Plans | 1 | Investing.com Deutsch | ||
| SANTEN PHARMACEUTICAL CO LTD ADR Aktie jetzt für 0€ handeln | |||||
| 13.05. | Santen Pharmaceutical Co., Ltd. reports Q4 results | 1 | Seeking Alpha | ||
| 07.04. | China's NMPA authorises Santen's glaucoma treatment application | 1 | Pharmaceutical Technology | ||
| 07.11.24 | Clearside Biomedical, Inc.: Clearside Biomedical Partner Arctic Vision Executes Commercial Collaboration Agreement with Santen Pharmaceutical Co., Ltd for ARVN001 Suprachoroidal Space Injection Therapy ... | 377 | GlobeNewswire (Europe) | - Partnership Creates New Opportunities to Address Unmet Needs Related to Posterior Segment Eye Diseases in China - - Agreement Provides Additional Validation for Clearside's Suprachoroidal Space... ► Artikel lesen |
5 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| NOVARTIS | 102,84 | +0,21 % | Novartis Pharma AG: Novartis completes acquisition of Regulus Therapeutics | Basel, June 25, 2025 - Novartis today announced that it has successfully completed its acquisition of Regulus Therapeutics Inc. ("Regulus"). With the completion of the acquisition, shares of common... ► Artikel lesen | |
| MPH HEALTH CARE | 18,350 | -2,39 % | Original-Research: MPH Health Care AG (von First Berlin Equity Research GmbH): Kaufen | Original-Research: MPH Health Care AG - from First Berlin Equity Research GmbH
17.06.2025 / 16:27 CET/CEST
Dissemination of a Research, transmitted by EQS News - a service of EQS Group.
The issuer... ► Artikel lesen | |
| HIGH TIDE | 1,970 | +1,76 % | High Tide startet anlässlich des "Canada Day" eine den ganzen Sommer andauernde "Buy Local"-Initiative | CALGARY, AB, 23. Juni 2025 / IRW-Press / High Tide Inc. ("High Tide" oder das "Unternehmen") (NASDAQ: HITI) (TSXV: HITI) (FWB: 2LYA), ein erfolgreiches, auf den
Einzelhandel ausgerichtetes Unternehmen... ► Artikel lesen | |
| COMPASS PATHWAYS | 2,360 | -0,84 % | Compass Pathfinder Limited: Compass Pathways Successfully Achieves Primary Endpoint in First Phase 3 Trial Evaluating COMP360 Psilocybin for Treatment-Resistant Depression | A single administration of COMP360 demonstrated a highly statistically significant and clinically meaningful reduction in symptom severity as measured by MADRS1 with a mean difference of -3.6... ► Artikel lesen | |
| PHARMASGP | 28,400 | 0,00 % | Dividendenbekanntmachungen (26.06.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) AUDIUS SE DE000A40ET13 - 0,2 EUR B&M EUROPEAN VALUE RETAIL SA LU1072616219 0,097 GBP 0,1136 EUR BUILD-A-BEAR WORKSHOP INC US1200761047 0... ► Artikel lesen | |
| SHANGHAI FOSUN PHARMACEUTICAL | 1,821 | +2,77 % | Fosun Pharma prices $34.25M Nature's Sunshine share sale | ||
| SEELOS THERAPEUTICS | 0,123 | -8,88 % | Delisting of Securities of Patria Latin American Opportunity Acquisition Corp.; Trevena, Inc.; Seelos Therapeutics, Inc.; DP Cap Acquisition Corp I; Chain Bridge I; Qomolangma Acquisition Corp.; Gaucho Group Holdings, Inc. ... | NEW YORK, March 26, 2025 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the Class A Ordinary Shares, unit, and warrant of Patria Latin American Opportunity Acquisition... ► Artikel lesen | |
| PROMINO NUTRITIONAL SCIENCES | 0,034 | -100,00 % | Promino Nutritional Sciences, Inc.: Promino Nutritional Sciences Inc. Comments on Trading Halt | Burlington, Ontario--(Newsfile Corp. - May 20, 2025) - Promino Nutritional Sciences Inc. (CSE: MUSL) (OTC Pink: MUSLF) (FSE: 93X) (the "Company" or "Promino") provides an update on the trading halt... ► Artikel lesen | |
| SAVARA | 1,890 | +0,53 % | Savara Inc.: Savara Announces Encore Presentations From the Phase 3 IMPALA-2 Trial of Molgramostim Inhalation Solution (Molgramostim) in Patients With Autoimmune Pulmonary Alveolar Proteinosis (aPAP) at Two Upcoming Scientific Conferences | Savara Inc. (Nasdaq: SVRA) (the Company), a clinical-stage biopharmaceutical company focused on rare respiratory diseases, announced encore presentations of top-line data from the pivotal, Phase... ► Artikel lesen | |
| EVOLUS | 7,950 | +1,27 % | XFRA EVL: WIEDERAUFNAHME/RESUMPTION | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen | |
| ATYR PHARMA | 4,200 | -2,33 % | aTyr Pharma to be added to Russell 2000 and Russell 3000 indexes | ||
| EVOKE PHARMA | 3,840 | -100,00 % | Evoke Pharma, Inc.: Evoke Pharma Reports First Quarter 2025 Financial Results and Provides Business Update | Q1 2025 Net Product Sales Increased 77% Year-over-Year to $3.1 Million Sustained Momentum Driven by Growing Prescriber Adoption and Repeat Patient Use SOLANA BEACH, Calif., May 13, 2025 (GLOBE NEWSWIRE)... ► Artikel lesen | |
| CIPHER PHARMACEUTICALS | 7,800 | -2,50 % | Cipher Pharmaceuticals Announces Results of Annual and Special Meeting of Shareholders | ||
| IMMUNOPRECISE ANTIBODIES | 0,995 | +5,29 % | ImmunoPrecise Antibodies Ltd. - 6-K, Report of foreign issuer | ||
| STEVANATO GROUP | 21,800 | +2,83 % | Stevanato Group S.p.A.: Stevanato Group to Participate in Upcoming Investor Conferences | Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, today... ► Artikel lesen |
SANTEN PHARMACEUTICAL CO LTD ADR gehört der Branche Pharma an. Mit einer aktuellen Kursveränderung von 0,000 (0,00 %) liegt der Kurs bei 10,000 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu SANTEN PHARMACEUTICAL CO LTD ADR finden Sie auf Wallstreet Online.